Atlas Trials

Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid Leukemia

Clinical trial NCT01106144 · UNKNOWN

Trial details

NCT number
NCT01106144
Sponsor
Samsung Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Patients With Acute Myeloid LeukemiaPatients Receiving Induction/Consolidation Chemotherapy
Start date
2010-05-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.